Recent clinical trials and optical control as a potential strategy to develop microtubule-targeting drugs in colorectal cancer management

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

1792

Figures (1-3)

237

Tables (1-3)

284

Sum=2383

Publishing Process of This Article

Item

Count

Browse

Download

225

Sum=305

Apr 7, 2024 (publication date) through Jan 8, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Apr 7, 2024; 30(13): 1780-1790
Published online Apr 7, 2024. doi: 10.3748/wjg.v30.i13.1780

Table 2 Recruiting docetaxel study in colorectal cancer

Clinical trial number	Treatment	Stage	Country
NCT04553692	IGM-844 + FOLFIRI (+ bevacizumab) (docetaxel included as a part)	Phase I	United States
NCT04256707	Selinexor, docetaxel, pembrolizumab, FOLFIRI	Phase I/II	Israel
NCT02817633	TSR-022, nivolumab, TSR-042, 033, docetaxel, pemetrexed, cisplatin, carboplatin	Phase I	United States
NCT05714553	Fosifloxuridine nafalbenamide, leucovorin, pembrolizumab, docetaxel	Phase I/II	United Kingdom
NCT04895709	BMS-986340, 936558-01, docetaxel	Phase I/II	United States
NCT04894370	(Sample collection)	Phase II	France

Citation: Kita K, Burdowski A. Recent clinical trials and optical control as a potential strategy to develop microtubule-targeting drugs in colorectal cancer management. World J Gastroenterol 2024; 30(13): 1780-1790
URL: https://www.wjgnet.com/1007-9327/full/v30/i13/1780.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i13.1780